Evidence map›Paper›PMID 34732165›Full record

ArticleBMC pediatrics2021

Treatment device for neonatal birth asphyxia related Hypoxic Ischemic Encephalopathy.

Rediet Zewdie, Lidet Getachew, Geremew Dubele, Ababo Oluma, Gedion Israel, Kokeb Dese, Gizeaddis Lamesgin Simegn

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rediet ZewdieSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Lidet GetachewSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Geremew DubeleSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Ababo OlumaSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Gedion IsraelSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Kokeb DeseSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia.
Gizeaddis Lamesgin SimegnSchool of Biomedical Engineering, Jimma Institute of Technology, Jimma University, Jimma, Ethiopia. 1time.et@gmail.com.ORCID 0000-0003-1333-4555
Jimma University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBirth asphyxia is a leading cause of neonatal brain injury, morbidity, and mortality globally. It leads to a multi-organ dysfunction in the neonate and to a neurological dysfunction called Hypoxic Ischemic Encephalopathy (HIE). Cooling therapy is commonly used to slow or stop the damaging effects of birth asphyxia. However, most of the cooling devices used in the healthcare facility do not have a rewarming functionality after cooling therapy. A separate rewarming device, usually a radiant warmer or incubator is used to rewarm the infant after therapy, causing additional burden to the healthcare system and infant families. The objective of this project was, therefore, to design and develop a cost-effective and efficient total body cooling and rewarming device.

methodsOur design includes two water reservoirs that operate by pumping cold and warm sterile water to a mattress. After decreasing the infant's core body temperature to 33.5 °C, the system is designed to maintain it for 72 h. Feedback for temperature regulation is provided by the rectal and mattress temperature sensors. Once the cooling therapy is completed, the system again rewarms the water inside the mattress and gradually increases the neonate temperature to 36.5-37 °C. The water temperature sensors' effectiveness was evaluated by adding 1000 ml of water to the reservoir and cooling and warming to the required level of temperature using Peltier. Then a digital thermometer was used as a gold standard to compare with the sensor's readings. This was performed for five iterations.

resultsThe prototype was built and gone through different tests and iterations. The proposed device was tested for accuracy, cost-effectiveness and easy to use. Ninety-three point two percent accuracy has been achieved for temperature sensor measurement, and the prototype was built only with a component cost of less than 200 USD. This is excluding design, manufacturing, and other costs.

conclusionA device that can monitor and regulate the neonate core body temperature at the neuroprotective range is designed and developed. This is achieved by continuous monitoring and regulation of the water reservoirs, mattress, and rectal temperatures. The device also allows continuous monitoring of the infant's body temperature, mattress temperature, reservoir temperature, and pulse rate. The proposed device has the potential to play a significant role in reducing neonatal brain injury and death due to HIE, especially in low resource settings, where the expertise and the means are scarce.

Indexed as

Asphyxia NeonatorumHypothermia, InducedHypoxia-Ischemia, BrainAsphyxiaBody TemperatureHumansInfantInfant, NewbornBirth asphyxiaCooling therapyHIEHypoxic Ischemic EncephalopathyTherapeutic Hypothermia

Identifiers

PMID34732165
PMCPMC8564992
OpenAlexW3195765611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.